Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions
- PMID: 11727263
- DOI: 10.1053/hupa.2001.28949
Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions
Abstract
Monoclonal adrenocortical lesions have been characterized by an inverse correlation between proliferation and apoptosis, and polyclonal lesions show a direct correlation. Their relationship with the vascular pattern remains unknown in adrenocortical nodular hyperplasias (ACNHs), adenomas (ACAs), and carcinomas (ACCs). We studied 20 ACNHs, 25 ACAs, and 10 ACCs (World Health Organization classification criteria) from 55 women. The analysis included X-chromosome inactivation assay (on microdissected samples), slide and flow cytometry, and in situ end labeling. Endothelial cells were stained with anti-CD31, and the blood vessel area and density were quantified by image analysis in the same areas. Appropriate tissue controls were run in every case. Regression analyses between kinetic and vascular features were performed in both polyclonal and monoclonal lesions. Polyclonal patterns were observed in 14 of 18 informative ACNHs and 3 of 22 informative ACAs, and monoclonal patterns were seen in 4 of 18 ACNHs, 19 of 22 ACAs, and 9 of 9 ACCs. A progressive increase in microvessel area was observed in the ACNH-ACA-ACC transition but was statistically significant between benign and malignant lesions only (191.36 +/- 168.32 v 958.07 +/- 1279.86 microm(2); P < .0001). In addition, case stratification by clonal pattern showed significant differences between polyclonal and monoclonal benign lesions; 6% of polyclonal and 57% of monoclonal lesions had microvessel area >186 microm(2) (P = .0000008). Monoclonal lesions showed parallel trends (but with opposite signs) for microvessel area and density in comparison with proliferation and apoptosis, whereas polyclonal lesions showed inverse trends. In conclusion, the kinetic advantage of monoclonal adrenal cortical lesions (increased proliferation, decreased apoptosis) is maintained by parallel increases in microvessel area and density.
Copyright 2001 by W.B. Saunders Company
Similar articles
-
DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.Hum Pathol. 2006 Oct;37(10):1295-303. doi: 10.1016/j.humpath.2006.04.025. Epub 2006 Jul 18. Hum Pathol. 2006. PMID: 16949934
-
Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex.Am J Pathol. 2000 Jan;156(1):311-9. doi: 10.1016/S0002-9440(10)64732-3. Am J Pathol. 2000. PMID: 10623680 Free PMC article.
-
Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.Endocr Relat Cancer. 2008 Jun;15(2):465-74. doi: 10.1677/ERC-07-0081. Endocr Relat Cancer. 2008. PMID: 18508999
-
Molecular markers and the pathogenesis of adrenocortical cancer.Oncologist. 2008 May;13(5):548-61. doi: 10.1634/theoncologist.2007-0243. Oncologist. 2008. PMID: 18515740 Review.
-
The molecular basis of adrenocortical cancer.Cancer Genet. 2012 Apr;205(4):131-7. doi: 10.1016/j.cancergen.2012.02.009. Cancer Genet. 2012. PMID: 22559973 Review.
Cited by
-
Ang-Tie Angiogenic Pathway Is Distinctively Expressed in Benign and Malignant Adrenocortical Tumors.Int J Mol Sci. 2022 May 17;23(10):5579. doi: 10.3390/ijms23105579. Int J Mol Sci. 2022. PMID: 35628389 Free PMC article.
-
Diagnostic Role of Prostate-Specific Membrane Antigen in Adrenocortical Carcinoma.Front Endocrinol (Lausanne). 2019 Apr 16;10:226. doi: 10.3389/fendo.2019.00226. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31040822 Free PMC article.
-
Association between microvessel density and histologic grade in renal cell carcinomas.Pathol Oncol Res. 2007;13(2):145-8. doi: 10.1007/BF02893490. Epub 2007 Jul 3. Pathol Oncol Res. 2007. PMID: 17607376
-
Angiogenesis in the Normal Adrenal Fetal Cortex and Adrenocortical Tumors.Cancers (Basel). 2021 Mar 1;13(5):1030. doi: 10.3390/cancers13051030. Cancers (Basel). 2021. PMID: 33804534 Free PMC article. Review.
-
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.Int J Mol Sci. 2012;13(2):1951-2011. doi: 10.3390/ijms13021951. Epub 2012 Feb 13. Int J Mol Sci. 2012. PMID: 22408433 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources